Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Alx Oncology Holdings Inc (ALXO)

Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ALX Oncology Announces Acceptance of Phase 2 ASPEN-06 Trial Results for Presentation at 2025 ASCO Gastrointestinal Cancers Symposium Quiver Quantitative, Inc. - Wed Dec 18, 5:24PM CST

ALX Oncology's clinical trial results for evorpacept will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium.Quiver AI SummaryALX Oncology Holdings Inc. announced that the updated results...

ALXO : 1.6200 (+9.46%)
Early-Onset Cancer Trends Spark Interest in Promising Oncology Pipelines BayStreet.ca - Wed Dec 18, 8:38AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – The American Cancer Society has unveiled its Advances in Oncology – 2024 Research Highlights report,...

ONCY : 0.8310 (-6.36%)
PSNL : 5.75 (+9.32%)
ALXO : 1.6200 (+9.46%)
ONC.TO : 1.19 (-9.16%)
NVCT : 4.52 (-3.62%)
TEM : 35.54 (+7.60%)
ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium GlobeNewswire - Wed Dec 18, 7:00AM CST

ALXO : 1.6200 (+9.46%)
ALX Oncology to Host Webcast on December 17 Featuring Phase 1b/2 Trial Data for Evorpacept in Metastatic Breast Cancer Quiver Quantitative, Inc. - Thu Dec 12, 5:24PM CST

ALX Oncology will host a webcast on December 17 to discuss new clinical trial data for evorpacept in breast cancer.Quiver AI SummaryALX Oncology Holdings Inc. will host a virtual event on December 17,...

ALXO : 1.6200 (+9.46%)
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024 GlobeNewswire - Thu Dec 12, 7:00AM CST

ALXO : 1.6200 (+9.46%)
ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer GlobeNewswire - Tue Dec 10, 8:00AM CST

ALXO : 1.6200 (+9.46%)
ALX Oncology to Participate in the Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Tue Nov 26, 7:00AM CST

ALXO : 1.6200 (+9.46%)
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer GlobeNewswire - Thu Nov 14, 7:00AM CST

ALXO : 1.6200 (+9.46%)
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Thu Nov 7, 3:00PM CST

ALXO : 1.6200 (+9.46%)
ALX Oncology Announces November Investor Conference Participation GlobeNewswire - Mon Nov 4, 7:00AM CST

ALXO : 1.6200 (+9.46%)

Barchart Exclusives

3 Highly-Rated Dividend Stocks To Buy on the Dip Barchart - Fri Dec 20, 6:00PM CST
Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot